HER2 Support Group Forums - View Single Post

reets · 08-28-2015, 01:50 PM

Thanks so much for the very informative response. Yes we are all different but it can be comforting to compare stats and have numbers that establish a benchmark to make treatment decisions under different protocols.
Good to know that the normal ranges for CA15-3 can vary so much. In FR, it is <25 I went down to 22 and it's inched up to 27 over the last three sessions (9 weeks). Perhaps that's why my Onc did not seem worried.
I will ask next time about the HER2 serum test if it may be more accurate; not sure if I have taken this.
I will also look into the Genetech patient access program to see if Perjeta is available internationally. They also produce Kadcyla in the US and I believe, is owned by Roche Pharmaceuticals. Perjeta is used here with Herciptin but ONLY 1st line. The combo seems more effective so I want to know future options & if this access program can help.
Continued NED for you!!

08-28-2015, 01:50 PM	#16
reets Junior Member Join Date: Feb 2015 Posts: 2	Re: lung mets, CT scan, and going off chemo Thanks so much for the very informative response. Yes we are all different but it can be comforting to compare stats and have numbers that establish a benchmark to make treatment decisions under different protocols. Good to know that the normal ranges for CA15-3 can vary so much. In FR, it is <25 I went down to 22 and it's inched up to 27 over the last three sessions (9 weeks). Perhaps that's why my Onc did not seem worried. I will ask next time about the HER2 serum test if it may be more accurate; not sure if I have taken this. I will also look into the Genetech patient access program to see if Perjeta is available internationally. They also produce Kadcyla in the US and I believe, is owned by Roche Pharmaceuticals. Perjeta is used here with Herciptin but ONLY 1st line. The combo seems more effective so I want to know future options & if this access program can help. Continued NED for you!!